Matters
- Drafted and filed a family of issued patents covering one of the client's core technologies.
- Researched and analyzed patents and patent applications held by key pioneers in technology, and counseled the client as to which to pursue for possible licensing.
- After a detailed analysis of a competitor's complex biotechnology patent, prepared and drafted opinion of counsel that client's proposed activity did not infringe the claims of the patent.
- Analyzed key patents and prepared and drafted opinion of counsel that a key patent is not valid and, thus, unenforceable against the client, after medical professionals in one of the client's hospitals received an indication that a pharmaceutical supplier might attempt to enforce a patent against them.
- Advised a Fortune 500 company in international patent procurement and the patent landscape relating to the ground-breaking CRISPR-Cas genome editing system.
- Provided patent counsel for a client with promising cell-based cancer therapy originating out of university, from start-up phase through successful acquisition by a big pharmaceutical company.
- Prepared patent analysis relating to branded biologics and guided IP strategy for Fortune 500 company contemplating production of biosimilars.
- Provided IP counsel for client in multi-billion dollar acquisition.
- Conducted patent due diligence for equity capital investors contemplating acquisition of a young agri-tech client with promising new technology for delivering RNAi molecules to food crops for pest control.
